Life Science Nation Newsletter  | July 13,  2017  |  Issue 222

  The LSN Story   |   Investor Platform   |   Company Platform   |   RESI Conference   |   Fundraising Consulting
Life Science Investor Mandates (July 6  - July 12)
Seeks Commercial-Stage Life Science and Healthtech Opportunities
Invests Strategically in Healthcare Materials Science and Nutrition
Opens US Office to Make Early Stage Equity Investments in Novel Platform Technologies
Looks For Early Stage Partners in Point of Care, Molecular and Tissue Diagnostics
In This Issue
Nature BioEntrepreneur Features LSN: Aligning Needs
LSN Services
Click to see investors that are a fit for your product and stage of development

Click here if you are a service provider and want to see a list of funded life science companies that are a fit for you

Click here if you want to receive free, targeted early stage dealflow for your life science investment firm

Free Copy of LSN's Book

LSN Videos
Must See Video---CEOs Explain Sourcing Family Offices, Working Your Pipeline and Cost of Campaigns - Tales from the Road at RESI
By Dennis Ford, Founder & CEO, Life Science Nation; Creator of RESI Conference Series

More frequently than not LSN captures content through its RESI panels that hits the nail on the head. The recent "Tales from the Road" Panel does just that. It's 6 minutes long but worth a viewing it if you are a scientist-entrepreneur or fundraising CEO. The most vital take-aways include how to source potential investors (particularly family offices), the process of "working" your pipeline of investors, and the costs associated with conducting a successful campaign.

The panel brought together successful biotech and medtech entrepreneurs to tell their stories of successfully raising capital. These are seasoned entrepreneurs who have been there done that and collectively have raised numerous private financing rounds and have exited multiple companies, with combined total deals exceeding $750 MM. They came to RESI San Diego to share their wisdom to fellow fundraising executives and provide insight in order to help their peers succeed...

By Natasha Eldridge, RESI Conference Manager, LSN

In last week's Next Phase newsletter, LSN announced the new Premier Partnering Plus service for RESI attendees. This week, we'd like to give you a more in depth look at how Premier Partnering Plus will take RESI Partnering to the next level, and show you an example of the extra information that will be available to attendees who opt for the Premier Partnering Plus pass. RESI Early Bird rates end on Friday, so now is the time to sign up.

Premier Partnering Plus users will receive: 
  • Detailed investment and deal mandate information to help dial in who they need to meet with based on fit 
  • Include specifics on the sectors and subsectors 
  • Indication interest, company and management team requirements 
  • Contact information and best way to reach out to an investor
Below, you can take a look at an example of what Premier Partnering Plus attendees will be able to see once RESI Partnering launches...

By Chris Cummings, Sr. Business Development Manager, LSN
Christine A. Wu, Senior Research Analyst, LSN

RESI is coming home to Boston and so is the RESI Innovation Challenge. This September's life science innovation competition will showcase the most promising new health technologies in the RESI Innovation Challenge. If you are fundraising and aim to build a presence in the Boston's booming healthcare scene, we'd like to see your application.

The RESI Innovation Challenge invites the top-tier early-stage companies in therapeutics, medical devices, diagnostics and healthcare IT to present from around the globe. All applicants will be vetted on the crucial balance of the quality of the company's scientific innovation and the investment potential based on the company current standings and management team...